ArticleJournal for immunotherapy of cancer2019

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site.

Alessandra Lopes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.